Furthermore, the therapeutic potential of alpha-1-antitrypsin was recently evaluated and revealed a promising result with a safety profile on various autoimmune diseases such as type 1 diabetes, rheumatoid arthritis, and systemic lupus erythematosus, which is possibly caused by an anti-inflammatory effect of the protein [37]. Here, SERPINA1 is linked to systemic lupus erythematosus.